Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

144.57
Delayed Data
As of 12:25pm ET
 -0.94 / -0.64%
Today’s Change
95.14
Today|||52-Week Range
147.45
+28.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line12.9M8.9M15.4M14.9M
 
 
 
 
 
Depreciation1.4M1.6M1.5M1.7M
 
 
 
 
 
Total Other Cash Flow8.2M7.7M6.6M3.1M
 
 
 
 
 
Funds From Operations29.5M20.9M32.6M26.7M
 
 
 
 
 
Funds From/For Other Operating Expenses3.1M3.6M-1.5M-10.6M
 
 
 
 
 
Net Cash Flow - Operating Activities26.4M17.4M34.1M37.3M
 
 
 
 
 
 
InvestingIncrease In Investments-67.3M-66.9M-43.5M-103.7M
 
 
 
 
 
Decrease In Investments47.1M69.6M28.0M60.8M
 
 
 
 
 
Capital Expenditures-5.1M-5.4M-13.6M-26.4M
 
 
 
 
 
Net Cash Flow Investing-25.3M-2.7M-29.1M-69.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.00--------
Long Term Debt Reduction0.00-83.0K-181.0K-182.0K
 
 
 
 
Net Proceeds Stock Sale2.8M3.8M2.5M3.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.0M2.6M964.0K7.4M
 
 
 
 
 
Other Uses - Financing15.0M4.6M290.0K207.0K
 
 
 
 
 
Net Cash Flow - Financing-11.2M1.7M3.0M10.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash212.0K60.0K-1.7M-460.0K
 
 
 
 
 
 
Net Change In Cash-10.2M16.4M8.0M-21.6M